Multiple sclerosis : clinical and laboratory research

The most recent articles from: Mult. Scler. July 2018

Mult. Scler. · Jul 2018

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.

Neurofilament light chain (NFL) is a cerebrospinal fluid (CSF) marker of neuroaxonal damage in multiple sclerosis (MS). ⋯ NFL in serum and CSF are highly correlated and plasma NFL levels decrease after switching to highly effective MS therapy. Blood NFL measurement can be considered as a biomarker for MS therapy response.

keep reading… or just mark as read…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!